Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: A multinational 10-year experience: Data from the Multicenter International CRT Study
Publication in refereed journal

Times Cited
Web of Science19WOS source URL (as at 23/09/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractIn the major trials of cardiac resynchronization therapy (CRT), the survival benefit of the therapy, relative to control subjects, increases with QRS duration. In the non-CRT heart failure population, however, a wide QRS duration is associated with a shorter survival. Relative survival benefit from a therapy, however, is not synonymous with a longer absolute survival. We sought to determine whether baseline QRS duration relates to the absolute survival after CRT.
All Author(s) ListGasparini M, Leclercq C, Yu CM, Auricchio A, Steinberg JS, Lamp B, Klersy C, Leyva F
Journal nameAmerican Heart Journal
Volume Number167
Issue Number2
Pages203 - +
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesCardiac & Cardiovascular Systems; CARDIAC & CARDIOVASCULAR SYSTEMS; Cardiovascular System & Cardiology

Last updated on 2021-24-09 at 00:12